Longitudinal change in HbA1c in patients with type 2 diabetes: comparison of short-acting, biphasic and basal insulin.

Rathmann, W; Strassburger, K; Kostev, K; Schröder-Bernhardi, D; Giani, G; Happich, M

Rathmann, W; Strassburger, K; Kostev, K; Schröder-Bernhardi, D; Giani, G; Happich, M.

Affiliation

Rathmann W; Institute of Biometrics and Epidemiology, German Diabetes Center, Leibniz Center for Diabetes Research at Heinrich Heine University, Auf'm Hennekamp 65, Düsseldorf, Germany. rathmann@ddz.uni-duesseldorf.de

Exp Clin Endocrinol Diabetes ; 117(5): 230-3, 2009 May.

Article in En | MEDLINE | ID: mdl-19226479

Subject(s)

Diabetes Mellitus, Type 2/blood; Diabetes Mellitus, Type 2/drug therapy; Glycated Hemoglobin/metabolism; Insulin/therapeutic use; Age of Onset; Aged; Aged, 80 and over; Arterial Occlusive Diseases/drug therapy; Diabetic Angiopathies/classification; Diabetic Angiopathies/drug therapy; Diabetic Nephropathies/drug therapy; Female; Germany; Glycated Hemoglobin/drug effects; Hospitalization/statistics & numerical data; Humans; Hypoglycemic Agents/therapeutic use; Longitudinal Studies; Male; Middle Aged

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Glycated Hemoglobin / Diabetes Mellitus, Type 2 / Insulin Type of study: Observational_studies Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Journal: Exp Clin Endocrinol Diabetes Year: 2009 Document type: Article

Fulltext

XML

PubMed Links

Search on Google